Patents by Inventor Rémi LEBEL

Rémi LEBEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11865118
    Abstract: The present invention relates to compounds of formula (I) and their use for treating or preventing a bacterial infection or as an antibacterial agent and/or as a ?-lactamase inhibitor.
    Type: Grant
    Filed: July 29, 2019
    Date of Patent: January 9, 2024
    Assignee: MUTABILIS
    Inventors: Julien Barbion, Audrey Caravano, Sophie Chasset, Francis Chevreuil, Frédéric Le Strat, Christophe Simon, Julie Brias, Rémi Lebel
  • Publication number: 20210275542
    Abstract: The present invention relates to compounds of formula (I) and their use for treating or preventing a bacterial infection or as an antibacterial agent and/or as a ?-lactamase inhibitor.
    Type: Application
    Filed: July 29, 2019
    Publication date: September 9, 2021
    Inventors: Julien Barbion, Audrey Caravano, Sophie Chasset, Francis Chevreuil, Frédéric Le Strat, Christophe Simon, Julie Brias, Rémi Lebel
  • Patent number: 10722520
    Abstract: A compound of formula (I) or a racemate, an enantiomer, a diastereoisomer, a geometric isomer or a pharmaceutically acceptable salt thereof, and its use as antibacterial agent.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: July 28, 2020
    Assignee: MUTABILIS
    Inventors: Julien Barbion, Audrey Caravano, Sophie Chasset, Francis Chevreuil, Fabien Faivre, Rémi Lebel, Nicolas Lecointe, Benoît Ledoussal, Frédéric Le-Strat, Christophe Simon, Chrystelle Oliveira, Géraldine Le Fralliec, Julie Brias, Laurence Farescour, Sophie Vomscheid, Sébastien Richard
  • Publication number: 20190224210
    Abstract: A compound of formula (I) or a racemate, an enantiomer, a diastereoisomer, a geometric isomer or a pharmaceutically acceptable salt thereof, and its use as antibacterial agent.
    Type: Application
    Filed: September 29, 2017
    Publication date: July 25, 2019
    Inventors: Julien BARBION, Audrey CARAVANO, Sophie CHASSET, Francis CHEVREUIL, Fabien FAIVRE, Rémi LEBEL, Nicolas LECOINTE, Benoît LEDOUSSAL, Frédéric LE-STRAT, Christophe SIMON, Chrystelle OLIVEIRA, Géraldine LE FRALLIEC, Julie BRIAS, Laurence FARESCOUR, Sophie VOMSCHEID, Sébastien RICHARD
  • Patent number: 10308602
    Abstract: The invention relates to a selenium compound. Said selenium compound has formula (I), where R1=alkyl; R2=H, R4C(=0), R4OC(=0), a-aminoacyl, CH3SeCH2CH2CH(NH2)C(=0), CH3SeCH2CH2CH(OH)C(=0); X=OH, OR3, NH2, NR4R5, ?-amino acid, CH3SeCH2CH2CH(COOH)NH—, CH3SeCH2CH2CH(COOH)0-; R3=alkyl; R4=alkyl, aryl; R5=H, alkyl, aryl; R4 and R5 which can together form a 5- or 6-membered cycloalkyl radical which can comprise a heteroatom; provided that when X=NH-terbutyl, R2?C(=0)CH3. Said compound can be used as a pharmaceutical substance, in particular as an antitumour substance.
    Type: Grant
    Filed: April 7, 2015
    Date of Patent: June 4, 2019
    Assignee: TETRAHEDRON
    Inventors: Jean-Claude Yadan, Irene Erdelmeier, Marc Moutet, Remi Lebel
  • Publication number: 20170114011
    Abstract: The invention relates to a selenium compound. Said selenium compound has formula (I), where R1=alkyl; R2=H, R4C(=0), R4OC(=0), a-aminoacyl, CH3SeCH2CH2CH(NH2)C(=0), CH3SeCH2CH2CH(OH)C(=0); X=OH, OR3, NH2, NR4R5, ?-amino acid, CH3SeCH2CH2CH(COOH)NH—, CH3SeCH2CH2CH(COOH)0-; R3=alkyl; R4=alkyl, aryl; R5=H, alkyl, aryl; R4 and R5 which can together form a 5- or 6-membered cycloalkyl radical which can comprise a heteroatom; provided that when X=NH-terbutyl, R2?C(=0)CH3. Said compound can be used as a pharmaceutical substance, in particular as an antitumour substance.
    Type: Application
    Filed: April 7, 2015
    Publication date: April 27, 2017
    Inventors: Jean-Claude YADAN, Irene ERDELMEIER, Marc MOUTET, Remi LEBEL